![N-(4-methoxyphenyl)-N'-[3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl]carbamimidate](https://static.cymitquimica.com/cas-image/380532-n-4-methoxyphenyl-n-3-1-phenylpropan-2-yl-123-oxadiazol-3-ium-5-yl-carbamimidate.png)
CAS: 66404-54-4 - N-(4-methoxyphenyl)-N'-[3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl]carbamimidate
Fórmula:C19H20N4O3
InChI:InChI=1/C19H20N4O3/c1-14(12-15-6-4-3-5-7-15)23-13-18(26-22-23)21-19(24)20-16-8-10-17(25-2)11-9-16/h3-11,13-14H,12H2,1-2H3,(H-,20,21,22,24)
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-[[(4-Methoxyphenyl)amino]carbonyl]-3-(1-methyl-2-phenylethyl)sydnone Imine REF: TR-M266315CAS: 66404-54-4 | - - - | 283,00 €~2.177,00 € | Mar 06 Ago 24 |
 | N-[[(4-Methoxyphenyl)amino]carbonyl]-3-(1-methyl-2-phenylethyl)sydnone imine REF: 3D-RCA40454CAS: 66404-54-4 | Min. 95% | A consultar | Jue 29 Ago 24 |
![N-[[(4-Methoxyphenyl)amino]carbonyl]-3-(1-methyl-2-phenylethyl)sydnone Imine](https://static.cymitquimica.com/products/TR/thumb/M266315.jpg)
N-[[(4-Methoxyphenyl)amino]carbonyl]-3-(1-methyl-2-phenylethyl)sydnone Imine
Producto controladoCAS:66404-54-4
Fórmula:
C19H20N4O3
Forma y color:
Neat
Peso molecular:
352.39
Ref: TR-M266315
| 5mg | 283,00 € | ||
| 25mg | 826,00 € | ||
| 100mg | 2.177,00 € |
Entrega estimada en Estados Unidos, el Martes 6 de Agosto de 2024
![N-[[(4-Methoxyphenyl)amino]carbonyl]-3-(1-methyl-2-phenylethyl)sydnone imine](https://static.cymitquimica.com/products/3D/thumb/RCA40454.jpg)
N-[[(4-Methoxyphenyl)amino]carbonyl]-3-(1-methyl-2-phenylethyl)sydnone imine
CAS:66404-54-4
Please enquire for more information about N-[[(4-Methoxyphenyl)amino]carbonyl]-3-(1-methyl-2-phenylethyl)sydnone imine including the price, delivery time and more …
Fórmula:
C19H20N4O3
Pureza:
Min. 95%
Peso molecular:
352.4 g/mol
Ref: 3D-RCA40454
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 29 de Agosto de 2024
